ACTIVE STUDIES RECRUITING: • J3L-MC-EZEF (ACCLAIM-Lp(a)) – Cardiovascular risk/ lipoprotein(a) - Lp(a) The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke. The study [...]